Korean biopharmaceutical companies are exploring opportunities at Bio Japan 2024 amid U.S.-China tensions, with major firms ...

The recent article in The Atlantic that belittles subject matter experts advocating for holistic health and questioning the ...

Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead has been testing it as an injectable form ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound become household names. These drugs, originally meant to treat diabetes, ...

Nifty has retraced 23.6 per cent of the entire fall seen from its all time high. Nifty has also closed near its 50 DMA(25,045 ...

Sustainability Report of Piramal Pharma Limited (the Company) for the financial year ended 2023-24 Sustainability Report of Piramal Pharma Limited (the Company) for the financial year ended 2023-24 ...

Programmed Cell Death Protein-1 (PD-1) represents endogenous mechanisms of negative immunoregulation. While the modulation of effector functions has been the major focus of PD-1 research, quick PD-1 ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 24,250.58 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Dividend announcements are not available. No other corporate actions details are available.